In a highly competitive process led by an Expert Council of successful entrepreneurs, Biotech venture capitalists and top industry executives, the company successfully demonstrated its capacity for rapid scalability and top-notch innovation. EIT Health and the Gold Track team will now support PhagoMed in achieving its business goals. As part of the Gold Track program, the company will benefit from tailored mentoring as well as matchmaking with leading investors and industry partners around the world.
The Gold Track program selects between 10 and 15 European Lifescience companies every year. These companies receive world-class mentoring and tailor-made exposure to potential investors and industry partners around the world. For more information on the Gold Track program, please follow this link.